Angiodynamics (ANGO) EBITDA Margin (2010 - 2026)
Angiodynamics (ANGO) reported EBITDA Margin of 16.51% for Q1 2026, down 266.0% on a YoY basis from 9.95% in Q1 2025, and down 114.17% quarter-over-quarter from 7.71% in Q4 2025.
Angiodynamics (ANGO) EBITDA Margin (2010 - 2026) Analysis & Trends
Angiodynamics has reported EBITDA Margin for 17 years, with the latest figure at 16.51% in Q1 2026.
- For the quarter ending Q1 2026, EBITDA Margin fell 266.0% year-over-year to 16.51%; the trailing twelve-month figure through Feb 2026 stood at 11.32% (up 584.0% YoY), and the FY2025 full-year result was 13.66%, up 4966.0% from the prior year.
- EBITDA Margin for Q1 2026 stood at 16.51%, down from 7.71% in the prior quarter.
- The five-year high for EBITDA Margin was 44.52% in Q3 2023, with the low at 265.88% in Q1 2024.
- Historically, EBITDA Margin has averaged 25.09% across 5 years, with a median of 14.07% in 2025.
- Annual changes were most pronounced in 2024 — EBITDA Margin tumbled 25482 bps — and 2025, when it jumped 25203 bps.
- Angiodynamics' EBITDA Margin stood at 9.5% in 2022, then plunged by 75 bps to 16.59% in 2023, then increased by 8 bps to 15.23% in 2024, then surged by 49 bps to 7.71% in 2025, then slumped by 114 bps to 16.51% in 2026.
- The last three EBITDA Margin figures came in at 16.51% (Q1 2026), 7.71% (Q4 2025), and 14.07% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 28.86% |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 1.97% |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 1.63% |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 34.92% |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 20.96% |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 4.04% |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -9.90% |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 13.65% |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 2.44% |
| 10 | Angiodynamics | 505.81 Mn | 468.00 Mn | 41.48 Mn | -16.51% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -16.51% |
| Nov 30, 2025 | -7.71% |
| Aug 31, 2025 | -14.07% |
| May 31, 2025 | -7.22% |
| Feb 28, 2025 | -13.85% |
| Nov 30, 2024 | -15.23% |
| Aug 31, 2024 | -19.41% |
| May 31, 2024 | -20.36% |
| Feb 29, 2024 | -265.88% |
| Nov 30, 2023 | -16.59% |
| Aug 31, 2023 | 44.52% |
| May 31, 2023 | -22.88% |
| Feb 28, 2023 | -11.06% |
| Nov 30, 2022 | -9.50% |
| Aug 31, 2022 | -16.31% |
| May 31, 2022 | -7.35% |
| Feb 28, 2022 | -7.16% |
| Nov 30, 2021 | -11.09% |
| Aug 31, 2021 | -10.52% |
| May 31, 2021 | -28.09% |